Researchers have developed a blood test that may detect early pancreatic cancer, one of the deadliest forms of cancer. The new test could improve survival rates from pancreatic cancer, which tends to be diagnosed at late stages when therapy is less likely to be effective

Read Full Article

#EarlyDetection #PancreaticCancer #BloodTest #CancerResearch #Survival

Half of all men over 60 have prostate cancer – an AI diagnostic tool could identify which need followup. Examinations have detected prostate cancer in 10 per cent of 50-year-olds, 50 per cent of 60-year-olds and approximately 70 per cent of men over the age of 80.

Read Full Article

#ProstateHealth #AIDiagnostic #MensHealth #ProstateCancerAwareness #EarlyDetection

The Millisecond That Could Change Cancer Treatment

Read Full Article

#CancerResearch #PrecisionMedicine #MilisecondBreakthrough #EarlyDetection #OncologyInnovation

Investigational blood biomarker panel may improve detection of pancreatic cancer

Read Full Article

#PancreaticCancer #Biomarkers #EarlyDetection

Researchers at Charles University's Second Faculty of Medicine found that novel "stress-test" memory exams can detect Alzheimer's years earlier than standard tests

Read Full Article

#AlzheimersPrediction #MemoryTest #EarlyDetection

A new sensor could enable earlier detection of bladder cancer: « Using a catheter coated with carbon nanotubes, researchers can detect biomarkers produced by cancer cells in the bladder. »

Read Full Article

#BladderCancer #EarlyDetection #Biomarkers

A Blood Test May Detect the Conditions That Lead to Lung Cancer Years Before It Appears

Read Full Article

#LungCancer #EarlyDetection #BloodTest

UC Berkeley, UCSF AI model reduces screening time for breast cancer in high-risk patients

Read Full Article

#BreastCancer #AIMedicine #EarlyDetection

Researchers have identified RNA biomarkers, known as “SECmeres”, that could provide a simple blood test for earlier Alzheimer's diagnosis

Read Full Article

#AlzheimersResearch #RNA biomarkers #EarlyDetection

Painless Swab Detects Oral Cancers in an Hour, With Over 95% Accuracy | The quantitative Malignancy Index Diagnostic System (qMIDS), involves using a brush to swab the suspect lesion, and then analyzing it for signs of mRNA expression from four specific genes linked to oral cancer.

Read Full Article

#OralCancer #EarlyDetection #qMIDS

Blood-Based Test Can Predict Risk of Developing Symptoms of Alzheimer's Up to a Decade Early

Read Full Article

#AlzheimersPrevention #BloodTest #EarlyDetection

A vaccine to prevent pancreatic cancer in high-risk individuals was safe and elicited durable immune responses. After a median follow-up of 16.5 months, none of the participants developed pancreatic cancer, and some of the precancerous lesions shrank or stopped growing.

Read Full Article

#PancreaticCancer #VaccineResearch #EarlyDetection

A new liquid biopsy blood test can now detect pancreatic cancer much earlier, when it’s not only more treatable but also when it’s precancerous and potentially curable. Pancreatic cancer has the lowest survival rates of any cancer. 90% have tumors detected at when the malignancy has already spread.

Read Full Article

#PancreaticCancer #LiquidBiopsy #EarlyDetection

Only 13% of cancers are caught through screening, while a fifth to half are first found in an emergency department.

Read Full Article

#CancerScreening #EmergencyRoom #EarlyDetection

A large prospective study found that a multicancer blood test identified cancer signals across 17 broad cancer types, including ovarian, lung, and breast cancers. The test correctly predicted cancer diagnoses in 60.3% of cases, with 99.64% specificity

Read Full Article

#CancerScreening #MultiCancerTest #EarlyDetection

🩸 First papers from the large-scale NHS cancer blood test trial, involving 142,000 volunteers aged 50–77, have been published in leading journals, assessing the Galleri® multi-cancer early detection (MCED) test.

📄 One paper in the New England Journal of Medicine shows fewer people diagnosed with stage 4 cancers in the test group, with more early-stage diagnoses and fewer emergency diagnoses, but no overall difference in late-stage cancers (stages 3 & 4 combined) compared to the control group.

🔬 The second paper in Nature Medicine reports the Galleri® test's accuracy: around one-third of cancer patients received a positive signal, while less than 0.5% of those without cancer had a false positive result.

#CancerResearch #NHS #EarlyDetection

An FDA advisory committee has recommended Galleri for approval, an early detection blood test designed to look for several cancers at once. It can flag a possible cancer signal, pointing doctors towards the part of the body where it most likely came from.

Read Full Article

#CancerDetection #EarlyDetection #GalleriTest

Scientists found some men lose the Y chromosome in cells that still look completely normal. Loss is higher next to tumors than in men with no cancer, and higher still in tumors. It does not prove this causes cancers, but may one day help doctors spot trouble earlier if a biopsy misses a small tumor.

Read Full Article

#YChromosome #CancerBiomarkers #EarlyDetection

📈 Cancer Cases Surge in Under-50s: Major research in England reveals significant increases in early-onset prostate, bowel, kidney, and uterine cancers. Prostate cancer diagnoses quadrupled since 2001, while bowel, kidney, and uterine cases more than doubled.

🌍 Global Trend with Local Impact: Similar "significant increases" in early-onset cancers were identified in the US and Netherlands for certain types, though lung cancer declined in all three countries, linked to reduced smoking.

💡 Lifestyle Factors Key: Experts point to the global obesity epidemic, poor diets, and insufficient exercise as major contributors, alongside increased awareness and earlier diagnosis. About 40% of cancers are linked to modifiable risks.

🔬 Research and Prevention Focus: New trials and government initiatives are underway in England to investigate the rise in early-onset cancers, particularly bowel cancer, and to improve early diagnosis and prevention strategies.

#CancerResearch #PublicHealth #EarlyDetection

A simple blood test may spot Crohn's and ulcerative colitis up to 10 years before diagnosis. Scientists studied 2,000 blood samples and found people who later got bowel disease had distinct antibody patterns, including more antibodies to the glandular fever virus, years before any symptoms shows.

Read Full Article

#Crohn disease #UlcerativeColitis #EarlyDetection